In vitro antibacterial activity of ethanolic Eugenia uniflora leaf extract and molecular docking study of myricetin as potential antibacterial compound

Authors

  • Putu Ririn Andreani Department of Pharmacy, Faculty of Pharmacy and Health Sciences, Universitas Pendidikan Nasional, Denpasar, 80244, Indonesia
  • Ni Kadek Mila Seni Puspita Dewi Department of Pharmacy, Faculty of Pharmacy and Health Sciences, Universitas Pendidikan Nasional, Denpasar, 80244, Indonesia
  • Ni Luh Putu Kris Monika Yanti Department of Pharmacy, Faculty of Pharmacy and Health Sciences, Universitas Pendidikan Nasional, Denpasar, 80244, Indonesia
  • Syamsun Jaya Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand

DOI:

https://doi.org/10.35814/jifi.v24i2.2162

Keywords:

Antibacterial activity, Bacillus cereus, Eugenia uniflora, molecular docking

Abstract

Bacillus cereus is an opportunistic foodborne pathogen that frequently contaminates food products and causes diarrheal or emetic food poisoning, making it a continuing concern for food safety. The present study evaluated the antibacterial activity of a 70% ethanolic leaf extract of Eugenia uniflora against B. cereus while exploring its possible mechanism of action through molecular docking. Leaf extraction was carried out by maceration with 70% ethanol, followed by phytochemical screening to determine the major secondary metabolites. Antibacterial activity was assessed using the disk diffusion method with extract concentrations of 30%, 40%, and 50%. Phytochemical analysis identified flavonoids, tannins, saponins, steroids, and triterpenoids in the extract. Growth inhibition of B. cereus was observed at all tested concentrations, with inhibition zones ranging from 6.96±0.45 mm to 7.70±0.23 mm, while azithromycin 1% as the positive control showed a higher inhibition zone of 13.70±0.31 mm. Docking analysis further demonstrated that myricetin exhibited favorable binding toward phosphatidylinositol-specific phospholipase C (PI-PLC) from B. cereus (PDB ID: 1GYM), with a predicted binding affinity of −7.8 kcal/mol, suggesting a potential molecular basis for the observed antibacterial activity. Overall, these findings highlight the promise of E. uniflora leaves as a natural source of antibacterial compounds against B. cereus, although additional experimental studies are required to validate the proposed mechanism and confirm the activity of individual phytochemicals through in vitro and in vivo investigations.

References

[1] V. Albert et al., “Comprehending the risk of foodborne and waterborne disease outbreaks: Current situation and control measures with Special reference to the Indian Scenario,” Heliyon, vol. 10, no. 16, pp. 1–18, 2024.

[2] S. Yang, Y. Wang, Y. Liu, K. Jia, Z. Zhang, and Q. Dong, “Cereulide and Emetic Bacillus cereus: Characterizations, Impacts and Public Precautions,” Foods, vol. 12, no. 4, pp. 1–23, 2023.

[3] R. Dietrich, N. Jessberger, M. Ehling-Schulz, E. Märtlbauer, and P. E. Granum, “The Food Poisoning Toxins of Bacillus cereus,” Toxins, vol. 13, no. 2, pp. 1–48, 2021.

[4] C. Prince and J. Kovac, “Regulation of Enterotoxins Associated with Bacillus cereus Sensu Lato Toxicoinfection,” Appl Environ Microbiol, vol. 88, no. 13, pp. 1–12, 2022.

[5] B. N. Guedes et al., “Natural antibiotics against antimicrobial resistance: sources and bioinspired delivery systems,” Braz J Microbiol, vol. 55, no. 3, pp. 2753–2766, 2024.

[6] A. C. Gonçalves et al., “Plant-Derived Bioactive Compounds: One Health Perspective,” Applied Sciences, vol. 16, no. 1, pp. 1–28, 2025.

[7] R. Latif and T. Nawaz, “Medicinal plants and human health: a comprehensive review of bioactive compounds, therapeutic effects, and applications,” Phytochem Rev, vol. 25, no. 3, pp. 2299–2342, 2026.

[8] J. Gonçalves, N. Hontman, R. Perestrelo, and J. S. Câmara, “A Comparative Study of the Biological Properties of Eugenia uniflora L. Fruits and Leaves Related to the Prevention of Cardiovascular Diseases,” Life, vol. 15, no. 2, p. 147, 2025.

[9] M. Sobeh et al., “A Polyphenol-Rich Fraction from Eugenia uniflora Exhibits Antioxidant and Hepatoprotective Activities In Vivo,” Pharmaceuticals, vol. 13, no. 5, p. 84, 2020.

[10] N. F. Shamsudin et al., “Antibacterial Effects of Flavonoids and Their Structure-Activity Relationship Study: A Comparative Interpretation,” Molecules, vol. 27, no. 4, p. 1149, 2022.

[11] J. B. Do Nascimento and J. G. M. Da Costa, “Flavonoids: A Review of Antibacterial Activity Against Gram‐Negative Bacteria,” International Journal of Microbiology, vol. 2025, no. 1, pp. 1–19, 2025.

[12] A. Sharyan, E. N. Bifari, and R. M. El-Shishtawy, “Exploring Myricetin’s biological impact in hybrid compounds for enhanced bioactivities,” Results in Chemistry, vol. 23, p. 103151, 2026.

[13] M. S. Rusdi, T. L. Febrianti, Y. Al-Annur, and S. K. Sita, “Antioxidant and Antihyperglycemic Effects of Bay Leaf (Syzygium polyanthum [Wight.] Walp) Kombucha in Alloxan-Induced Diabetic Mice,” Science Essence Journal, vol. 41, no. 2, pp. 168–179, 2025.

[14] N. L. P. K. M. Yanti, M. I. Dasilva, P. R. Andreani, and I. K. Suardiana, “ANTIBACTERIAL ACTIVITY TEST OF FENNEL LEAVES AND STEMS (Foeniculum vulgare Mill.) AGAINST BACTERIA Cutibacterium acnes AND Staphylococcus epidermidis,” Journal Pharmaceutical Science and Application, vol. 7, no. 2, pp. 64–72, 2025.

[15] Y. D. Rattmann et al., “Analysis of Flavonoids from Eugenia uniflora Leaves and Its Protective Effect against Murine Sepsis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, pp. 1–9, 2012.

[16] M. N. Samy, S. Sugimoto, K. Matsunami, H. Otsuka, and M. S. Kamel, “Bioactive compounds from the leaves of Eugenia uniflora,” Journal of Natural Products, vol. 7, pp. 37–47, 2014.

[17] A. O. Oriola, G. M. Miya, M. Singh, and A. O. Oyedeji, “Flavonol Glycosides from Eugenia uniflora Leaves and Their In Vitro Cytotoxicity, Antioxidant and Anti-Inflammatory Activities,” Sci. Pharm., vol. 91, no. 42, pp. 1–14, 2023.

[18] T. R. Falcão et al., “Crude extract and fractions from Eugenia uniflora Linn leaves showed anti-inflammatory, antioxidant, and antibacterial activities,” BMC Complement Altern Med, vol. 18, no. 1, pp. 1–12, 2018.

[19] D. Zeng et al., “Myricetin Potentiates Antibiotics Against Resistant Pseudomonas aeruginosa by Disrupting Biofilm Formation and Inhibiting Motility Through FimX-Mediated c-di-GMP Signaling Interference,” Biology, vol. 14, no. 7, p. 859, 2025.

[20] R. Goldstein, J. Cheng, B. Stec, and M. F. Roberts, “Structure of the S. aureus PI-Specific Phospholipase C Reveals Modulation of Active Site Access by a Titratable π-Cation Latched Loop,” Biochemistry, vol. 51, no. 12, pp. 2579–2587, 2012.

[21] N. Sergeev, M. Distler, M. Vargas, V. Chizhikov, K. E. Herold, and A. Rasooly, “Microarray analysis of Bacillus cereus group virulence factors,” Journal of Microbiological Methods, vol. 65, no. 3, pp. 488–502, 2006.

[22] C. Bai, L. Zhao, M. Rebecchi, M.-D. Tsai, and K. S. Bruzik, “Trans-Cyclization of Phosphatidylinositol Catalyzed by Phospholipase C from Streptomyces antibioticus,” J. Am. Chem. Soc., vol. 131, no. 24, pp. 8362–8363, 2009.

[23] H. Ahyayauch et al., “End-Product Diacylglycerol Enhances the Activity of PI-PLC through Changes in Membrane Domain Structure,” Biophysical Journal, vol. 108, no. 7, pp. 1672–1682, 2015.

[24] Y. Liu, J. Zhu, Z. Liu, Y. Zhi, C. Mei, and H. Wang, “Flavonoids as Promising Natural Compounds for Combating Bacterial Infections,” IJMS, vol. 26, no. 6, p. 2455, 2025.

[25] J. Kováč et al., “Therapeutic Potential of Flavonoids and Tannins in Management of Oral Infectious Diseases—A Review,” Molecules, vol. 28, no. 1, p. 158, 2022.

[26] K. Atkovska, J. Klingler, J. Oberwinkler, S. Keller, and J. S. Hub, “Rationalizing Steroid Interactions with Lipid Membranes: Conformations, Partitioning, and Kinetics,” ACS Cent. Sci., vol. 4, no. 9, pp. 1155–1165, 2018.

[27] Y. P. Timilsena, A. Phosanam, and R. Stockmann, “Perspectives on Saponins: Food Functionality and Applications,” IJMS, vol. 24, no. 17, pp. 1–22, 2023.

[28] R. D. Dos Santos et al., “Chemical Characterization and Antimicrobial Activity of Essential Oils and Nanoemulsions of Eugenia uniflora and Psidium guajava,” Antibiotics, vol. 14, no. 1, pp. 1–22, 2025.

[29] T. J. Hossain, “Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations,” EuJMI, vol. 14, no. 2, pp. 97–115, 2024.

[30] E. M. Fidelis, A. S. P. Savall, F. De Oliveira Pereira, C. B. Quines, D. S. Ávila, and S. Pinton, “Pitanga (Eugenia uniflora L.) as a source of bioactive compounds for health benefits: A review,” Arabian Journal of Chemistry, vol. 15, no. 4, pp. 1–22, 2022.

[31] Y. Taheri et al., “Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications,” BMC Complement Med Ther, vol. 20, no. 1, p. 241, 2020.

[32] Z. Zhang et al., “Research Progress on the Antibacterial Activity of Natural Flavonoids,” Antibiotics, vol. 14, no. 4, p. 334, 2025.

Downloads

Published

2026-08-31